Compare trend and price CCEL vs HCA
Loading...
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CCEL’s FA Score shows that 1 FA rating(s) are green whileHCA’s FA Score has 2 green FA rating(s).
- CCEL’s FA Score: 1 green, 4 red.
- HCA’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HCA’s TA Score shows that 6 TA indicator(s) are bullish.
- HCA’s TA Score: 6 bullish, 4 bearish.
Price Growth
CCEL (@Medical/Nursing Services) experienced а +8.73% price change this week, while HCA (@Medical/Nursing Services) price change was +2.05% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.31%. For the same industry, the average monthly price growth was +4.80%, and the average quarterly price growth was -8.43%.
Reported Earning Dates
CCEL is expected to report earnings on Apr 15, 2024.
HCA is expected to report earnings on Jan 30, 2024.
Industries' Descriptions
@Medical/Nursing Services (+0.31% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| CCEL | HCA | CCEL / HCA | |
| Capitalization | 40.2M | 67.3B | 0% |
| EBITDA | 6.98M | 13.6B | 0% |
| Gain YTD | 50.118 | 8.058 | 622% |
| P/E Ratio | 14.79 | 12.18 | 121% |
| Revenue | 31.2M | 63.2B | 0% |
| Total Cash | 1.21M | 891M | 0% |
| Total Debt | 12.5M | 41.1B | 0% |
CCEL | HCA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 31 Undervalued | |
PROFIT vs RISK RATING 1..100 | 97 | 21 | |
SMR RATING 1..100 | 12 | 45 | |
PRICE GROWTH RATING 1..100 | 38 | 50 | |
P/E GROWTH RATING 1..100 | 91 | 57 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HCA's Valuation (31) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CCEL (85) in the null industry. This means that HCA’s stock grew somewhat faster than CCEL’s over the last 12 months.
HCA's Profit vs Risk Rating (21) in the Hospital Or Nursing Management industry is significantly better than the same rating for CCEL (97) in the null industry. This means that HCA’s stock grew significantly faster than CCEL’s over the last 12 months.
CCEL's SMR Rating (12) in the null industry is somewhat better than the same rating for HCA (45) in the Hospital Or Nursing Management industry. This means that CCEL’s stock grew somewhat faster than HCA’s over the last 12 months.
CCEL's Price Growth Rating (38) in the null industry is in the same range as HCA (50) in the Hospital Or Nursing Management industry. This means that CCEL’s stock grew similarly to HCA’s over the last 12 months.
HCA's P/E Growth Rating (57) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CCEL (91) in the null industry. This means that HCA’s stock grew somewhat faster than CCEL’s over the last 12 months.
| HCA | |
|---|---|
| RSI ODDS (%) | 3 days ago 71% |
| Stochastic ODDS (%) | 3 days ago 49% |
| Momentum ODDS (%) | 3 days ago 70% |
| MACD ODDS (%) | 5 days ago 66% |
| TrendWeek ODDS (%) | 3 days ago 69% |
| TrendMonth ODDS (%) | 3 days ago 66% |
| Advances ODDS (%) | 3 days ago 66% |
| Declines ODDS (%) | 5 days ago 58% |
| BollingerBands ODDS (%) | 3 days ago 57% |
| Aroon ODDS (%) | 3 days ago 64% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LQFLX | 10.54 | 0.08 | +0.76% |
| Lord Abbett Focused Large Cap Value R3 | |||
| JAGIX | 71.40 | 0.24 | +0.34% |
| Janus Henderson Growth And Income T | |||
| ALMAX | 11.20 | 0.03 | +0.27% |
| Alger Weatherbie Specialized Growth A | |||
| RDCCX | 7.90 | 0.01 | +0.13% |
| Columbia Disciplined Value C | |||
| PBAIX | 14.37 | N/A | N/A |
| BlackRock Tactical Opportunities Instl | |||
CCEL and
Correlation & Price change
A.I.dvisor tells us that CCEL and ATIP have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CCEL and ATIP's prices will move in lockstep.
| Ticker / NAME | Correlation To CCEL | 1D Price Change % | ||
|---|---|---|---|---|
| CCEL | 100% | +4.79% | ||
| ATIP - CCEL | 10% Poorly correlated | N/A | ||
| AIH - CCEL | 6% Poorly correlated | -3.95% | ||
| NVOS - CCEL | 5% Poorly correlated | +4.20% | ||
| GBNH - CCEL | 5% Poorly correlated | +3.33% | ||
| HCA - CCEL | 4% Poorly correlated | +1.41% | ||
More | ||||
HCA and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCA has been loosely correlated with THC. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if HCA jumps, then THC could also see price increases.